U.S. Reaches $2.1 Billion Deal With Sanofi and GlaxoSmithKline For Coronavirus Vaccine
Federal government makes sixth and largest deal for coronavirus vaccine candidate as part of Operation Warp Speed.
Full Article
U.S. Reaches $2.1 Billion Deal With Sanofi and GlaxoSmithKline For Coronavirus Vaccine
NPR
0 shares
1 views
You might like
Related news coverage
Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus Vaccine
Motley Fool
The U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.
-
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
-
Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses
USATODAY.com
-
Sanofi, GlaxoSmithKline in $2.1 billion vaccine deal with U.S.
CBS News
-
GlaxoSmithKline, Sanofi get $2.1B to fund Covid-19 vaccine under Operation Warp Speed
bizjournals
Advertisement
More coverage
China daily infections jump to 101; Hong Kong warns of massive community outbreak
China reported 101 new confirmed cases of COVID-19 on Wednesday, the highest number in weeks, as the country continues to battle an..
Mid-Day